{"contentid": 488345, "importid": NaN, "name": "Tango Therapeutics to go public via merger with BCTG Acquisition", "introduction": "US biotech Tango Therapeutics has signed a deal with BCTG Acquisition, a special-purpose acquisition company, or SPAC, sponsored by San Diego's Boxer Capital, to go public through a reverse merger.", "content": "<p>US biotech Tango Therapeutics has signed a deal with BCTG Acquisition (Nasdaq: BCTG), a special-purpose acquisition company, or SPAC, sponsored by San Diego's Boxer Capital, to go public through a reverse merger.</p>\n<p>On closing of the transaction, which is expected in the third quarter of 2021, the company will be named Tango Therapeutics and led by Dr Barbara Weber, president and chief executive of Tango.</p>\n<p>Tango Therapeutics common stock is expected to be listed on Nasdaq under the ticker symbol TNGX. The combined company is expected to receive gross proceeds of around $353 million at the closing of the transaction (assuming no redemptions from BCTG&rsquo;s trust account).</p>\n<h2><strong>Summary of transaction</strong></h2>\n<p>Current Tango shareholders are converting 100% of their existing equity interests into common stock of the combined company. In addition to the approximately $167 million held in the BCTG trust account (less any redemptions), an additional group of premier healthcare investors has committed to participate in the transaction through a common stock PIPE of about $186 million at $10.00 per share.&nbsp;</p>\n<p>Proceeds from the transaction are expected to provide Tango with the capital needed to further develop its pipeline, including the following activities:</p>\n<ul>\n<li>Investigational New Drug (IND) filing for Tango&rsquo;s lead program, TNG908, an MTA-cooperative PRMT5 inhibitor, expected in the fourth quarter of 2021 and advance it into the clinic with a comprehensive development plan exploring multiple cancer types;</li>\n<li>IND filing for Tango&rsquo;s USP1 inhibitor expected in 2022 and advance it into the clinic for treatment of BRCA1-mutant breast, ovarian and prostate cancer;</li>\n<li>IND filing for an undisclosed target expected in 2023 and advance it into the clinic for treatment of STK11-mutant lung cancer; and</li>\n<li>Progressing multiple pre-clinical programs into development with the goal of filing one new IND every 12 to 18 months.</li>\n</ul>", "date": "2021-04-14 15:50:00", "meta_title": "Tango Therapeutics to go public via merger with BCTG Acquisition", "meta_keywords": "Tango Therapeutics, BCTG Acquisition, Merger, Reverse, M&A", "meta_description": "Tango Therapeutics to go public via merger with BCTG Acquisition", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-14 15:49:39", "updated": "2021-04-14 15:56:15", "access": NaN, "url": "https://www.thepharmaletter.com/article/tango-therapeutics-to-go-public-via-merger-with-bctg-acquisition", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "tango_therapeutics_company.jpg", "image2id": "merger-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Oncology", "topic_tag": "Companies, mergers and acquisitions, One to Watch Companies", "geography_tag": "USA", "company_tag": "BCTG Acquisition, Tango Therapeutics", "drug_tag": "TNG908", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-14 15:50:00"}